TORONTO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE)( OTCQX:BLEVF) is pleased to announce it has been granted a license by Health Canada to begin commercial production of cannabis oils.
“We are very pleased to be able to begin oil extraction on a commercial level,” said Beleave CEO Andrew Wnek, “The company has put a lot of time and effort into researching various extraction techniques and is looking forward to putting this knowledge to good use.”
Beleave Inc. is a biotech company and Beleave's wholly-owned subsidiary Beleave Kannabis Corp. (formerly First Access Medical Inc.) is a licensed producer pursuant to the ACMPR. Beleave's purpose-buil
t facility is located in Hamilton, Ontario.